|
Volumn 8, Issue 3 SUPPL. 2, 2007, Pages
|
To Treat or Not To Treat, That Is the Question: Proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-Term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ANALGESIC AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
COLECALCIFEROL;
ESTROGEN;
PAMIDRONIC ACID;
PARATHYROID HORMONE[1-34];
PLACEBO;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
VITAMIN D;
ARTICLE;
BONE DENSITY;
CANADA;
CASE MANAGEMENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIAGNOSTIC ERROR;
DIAGNOSTIC TEST;
DIET SUPPLEMENTATION;
DRUG ADMINISTRATION ROUTE;
DRUG COST;
DRUG TOLERABILITY;
ELDERLY CARE;
EVIDENCE BASED MEDICINE;
FALLING;
FRAGILITY FRACTURE;
FRAIL ELDERLY;
HEART DISEASE;
HIGH RISK PATIENT;
HUMAN;
INSTITUTIONAL CARE;
KINESIOTHERAPY;
LABORATORY TEST;
LIFE EXPECTANCY;
LONG TERM CARE;
LOW DRUG DOSE;
NURSING HOME PATIENT;
NUTRITION;
OSTEOPOROSIS;
PATIENT CARE;
PATIENT COMPLIANCE;
PATIENT MOBILITY;
PATIENT SELECTION;
POLYPHARMACY;
PRACTICE GUIDELINE;
PROGNOSIS;
REFLUX ESOPHAGITIS;
RISK FACTOR;
SUN EXPOSURE;
TREATMENT INDICATION;
|
EID: 33847667989
PISSN: 15258610
EISSN: 15389375
Source Type: Journal
DOI: 10.1016/j.jamda.2007.01.027 Document Type: Article |
Times cited : (10)
|
References (0)
|